InsiderSource

Zaks Tal Zvi

Director, Chief Medical Officer · SEC CIK 1690927
Insider at TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD ADAP Adaptimmune Therapeutics PLC MRNA Moderna, Inc.
Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$0
0 trades
Open-market sells
$28.73M
157 trades
Net flow
−$28.73M
Net selling
Total filings
199
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Dec 22, 2020 ΔOwn −21%

Zaks Tal Zvi sold $405K of MRNA, trimming their stake 21%.

−$405K
2,876 sh @ $141
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Dec 22, 2020 ΔOwn −9.6%

Zaks Tal Zvi sold $144.9K of MRNA, trimming their stake 10%.

−$144.9K
1,020 sh @ $142
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Dec 22, 2020 ΔOwn −36%

Zaks Tal Zvi sold $489.2K of MRNA, trimming their stake 36%.

−$489.2K
3,415 sh @ $143
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Dec 22, 2020 ΔOwn −53%

Zaks Tal Zvi sold $476.1K of MRNA, trimming their stake 53%.

−$476.1K
3,300 sh @ $144
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Dec 22, 2020 ΔOwn −83%

Zaks Tal Zvi sold $345.9K of MRNA, trimming their stake 83%.

−$345.9K
2,382 sh @ $145
Advertisement
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Dec 22, 2020 ΔOwn −100%

Zaks Tal Zvi sold $73.1K of MRNA, trimming their stake 100%.

−$73.1K
500 sh @ $146
MRNA
Moderna, Inc.
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed Dec 16, 2020 ΔOwn NEW
+$209.3K
10,000 sh @ $21
MRNA
Moderna, Inc.
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed Dec 16, 2020 ΔOwn +0.3%
+$483
34 sh @ $14
MRNA
Moderna, Inc.
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed Dec 16, 2020 ΔOwn +50%
+$61.1K
5,000 sh @ $12
MRNA
Moderna, Inc.
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed Dec 16, 2020 ΔOwn +67%
+$191.5K
10,000 sh @ $19
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Dec 16, 2020 ΔOwn −5.6%

Zaks Tal Zvi sold $216.3K of MRNA, trimming their stake 6%.

−$216.3K
1,402 sh @ $154
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Dec 16, 2020 ΔOwn −16%

Zaks Tal Zvi sold $579.2K of MRNA, trimming their stake 16%.

−$579.2K
3,733 sh @ $155
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Dec 16, 2020 ΔOwn −25%

Zaks Tal Zvi sold $769.2K of MRNA, trimming their stake 25%.

−$769.2K
4,922 sh @ $156
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Dec 16, 2020 ΔOwn −37%

Zaks Tal Zvi sold $865.8K of MRNA, trimming their stake 37%.

−$865.8K
5,509 sh @ $157
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Dec 16, 2020 ΔOwn −11%

Zaks Tal Zvi sold $158.4K of MRNA, trimming their stake 11%.

−$158.4K
1,000 sh @ $158
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Dec 16, 2020 ΔOwn −28%

Zaks Tal Zvi sold $376.6K of MRNA, trimming their stake 28%.

−$376.6K
2,358 sh @ $160
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Dec 16, 2020 ΔOwn −48%

Zaks Tal Zvi sold $466.8K of MRNA, trimming their stake 48%.

−$466.8K
2,907 sh @ $161
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Dec 16, 2020 ΔOwn −78%

Zaks Tal Zvi sold $404.4K of MRNA, trimming their stake 78%.

−$404.4K
2,502 sh @ $162
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Dec 16, 2020 ΔOwn −100%

Zaks Tal Zvi sold $114K of MRNA, trimming their stake 100%.

−$114K
701 sh @ $163

Frequently asked questions

How is Zaks Tal Zvi's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from Zaks Tal Zvi's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.